🟢 Strong Evidence
Loss of visceral fat through lifestyle interventions creates a lasting “metabolic legacy” that continues to protect against diabetes for up to a decade, even when body weight returns to baseline levels. Research from Ben-Gurion University of the Negev demonstrates that participants who lost visceral fat during an 18-month intervention maintained a 28% lower diabetes risk 10 years later, despite regaining their original weight.
Key takeaways
- Visceral fat reduction alone—not liver, pancreatic, or subcutaneous fat loss—drives long-term diabetes protection
- Participants maintained 28% lower diabetes risk for 10 years after intervention ended
- Metabolic benefits persisted despite complete weight regain to baseline levels
- Each 1% reduction in visceral fat correlated with sustained improvements in insulin sensitivity
Study at a Glance
| Source | International Journal of Obesity |
| Study type | Randomized controlled trial with 10-year follow-up |
| Sample size | N = 278 |
| Population | Adults with abdominal obesity and elevated liver fat |
| Country | Israel |
Diabetes Risk Reduction by Fat Type Lost
10-year follow-up results showing sustained metabolic benefits
Source: Ben-Gurion University of the Negev, 2024 | Georgian Medical Journal News
Metabolic memory challenges conventional weight loss thinking
The study followed 278 adults with abdominal obesity through an 18-month lifestyle intervention and subsequent 10-year observation period. Dr. Yftach Gepner, lead researcher at Ben-Gurion University’s School of Public Health, found that traditional weight-focused metrics failed to predict long-term metabolic benefits.
“The location and type of fat loss, rather than total weight reduction, determines lasting metabolic improvements,” according to the research published in the International Journal of Obesity. Participants underwent detailed body composition analysis using magnetic resonance imaging to distinguish between visceral, liver, pancreatic, and subcutaneous fat deposits.
The intervention combined Mediterranean diet principles with moderate physical activity, achieving average visceral fat reductions of 22% during the active phase. Researchers from multiple international institutions contributed to the decade-long follow-up analysis.
Visceral fat emerges as unique metabolic target
Unlike other fat deposits, visceral fat—the deep abdominal fat surrounding organs—showed unique associations with sustained diabetes protection. The World Health Organization estimates 422 million adults worldwide live with diabetes, making these findings particularly significant for prevention strategies.
Participants who achieved the greatest visceral fat loss maintained superior insulin sensitivity and glucose metabolism markers throughout the 10-year follow-up, despite weight regain. Liver fat and pancreatic fat reductions, while beneficial during the active intervention, did not translate to long-term metabolic protection.
The study’s findings align with emerging research on adipose tissue biology and its role in metabolic disease development. Traditional body mass index measurements failed to predict which participants would maintain diabetes protection.
Implications extend beyond individual interventions
These results challenge current obesity treatment paradigms that prioritize total weight loss over targeted fat reduction. The Centers for Disease Control and Prevention’s diabetes prevention guidelines may need updating to reflect these mechanistic insights.
Professor Iris Shai, senior author and nutrition researcher at Ben-Gurion University, noted the study’s implications for precision medicine approaches. The research suggests that interventions specifically targeting visceral fat reduction could provide more durable metabolic benefits than general weight loss programs.
Participants maintained improved inflammatory markers and insulin sensitivity measurements that correlated directly with their degree of visceral fat loss during the original intervention. This “metabolic memory” persisted independently of subsequent weight changes or dietary adherence.
Visceral fat reduction of just 1% translated to measurable improvements in insulin sensitivity that persisted for the entire 10-year follow-up period, regardless of weight regain
— Dr. Yftach Gepner, Ben-Gurion University School of Public Health (International Journal of Obesity, 2024)
What this means
Frequently asked questions
Why does visceral fat loss provide lasting protection when other fat reduction doesn’t?
Visceral fat produces inflammatory cytokines and hormones that directly interfere with insulin function. Removing this metabolically active tissue appears to reset inflammatory pathways in ways that persist long-term, unlike subcutaneous fat which is less metabolically active.
Can people specifically target visceral fat loss without losing total weight?
While spot reduction isn’t possible, aerobic exercise and Mediterranean dietary patterns preferentially reduce visceral fat even with modest total weight changes. Resistance training and stress reduction also help target deep abdominal fat deposits.
How can individuals measure their visceral fat levels?
DEXA scans and specialized body composition analyzers can estimate visceral fat, though MRI remains the gold standard. Waist circumference and waist-to-hip ratio provide accessible proxy measurements for clinical use.
These findings represent a paradigm shift toward understanding obesity as a heterogeneous condition where fat distribution matters more than total quantity. Future diabetes prevention strategies may prioritize sustainable lifestyle interventions that specifically target visceral adiposity, potentially offering more durable protection than traditional weight-focused approaches. The research provides compelling evidence that metabolic health improvements can persist far beyond active intervention periods when the right biological targets are addressed.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
